Abstract: The growing incidence of cancer raises an urgent need to develop effective diagnostic and therapeutic strategies. With the rapid development of nanomedicine, nanoscale metal-organic frameworks (NMOFs) presented promising potential in various biomedical applications in the last 2 decades, especially in cancer theranostics. Due to the unique features of NMOFs, including structural diversities, enormous porosity, multifunctionality and biocompatibility, they have been widely used to deliver imaging contrast agents and therapeutic drugs. Moreover, multiple types of contrast agents, anti-cancer drugs and targeting ligands could be co-delivered through one single NMOF to enable combination therapy. Co-delivering system using NMOFs helped to avoid multidrug resistance, to reduce adverse effects, to achieve imaging-guided precise therapy and to enhance anti-cancer efficacy. This review summarized the recent research advances on the application of NMOFs in biomedical imaging and cancer treatments in the last few years. The current challenges that impeding their translation to clinical practices and the perspectives for their future applications were also highlighted and discussed.
Introduction
The incidence of cancer is increasing rapidly and it is still one of the most devastating diseases threatening people's health. 1 Therapeutic strategies, including surgical intervention, radiotherapy (RT), and chemotherapy, are routine methods of cancer treatment in the clinic. However, owing to poor effects, intolerably systemic toxicity and high risk of recurrence, traditional treatments often fail to meet the clinical needs. Thus, there is an urgent need for safer and more effective treatment strategies to improve the survival rate of cancer patients. By integrating functions of diagnostics and therapeutics into a single system, cancer theranostics has attracted great attention in cancer research. 2, 3 With the rapid development of nanotechnology in the last 2 decades, nanoparticles have been used in cancer theranostics for more efficient early diagnoses and early therapies. 4 Metal-organic frameworks (MOFs) are a series of crystalline hybrid materials composed of metal ions or clusters and organic ligands. 5, 6 Recently, MOFs were scaled down to the nanometer sizes, namely nanoscale MOFs (NMOFs). NMOFs combine many unique properties into a single loading and delivery system, including high loading capacities, compositional and structural tenability, controllable and sustained drug release, excellent biocompatibility and intrinsic biodegradable. 7, 8 In addition, postsynthetic modification offers NMOFs more desired functionalities. 9, 10 Nanoscopic size of NMOFs enables them to accumulate at the tumor sites due to the enhanced permeability and retention (EPR) effect of tumors. 11 These unique features promote NMOFs' widely application in delivering imaging contrast agents and anticancer drugs as attractive theranostic platforms. 12 Based on the different microenvironment between normal and tumor tissues, tumor-targeting NMOFs can be designed to reduce the damage to normal tissues. According to the EPR effect, NMOFs can be accumulated at tumor sites, which is passive targeting. 13 On the other hand, active targeting can be achieved by adding targeting ligands on the surface of NMOFs. Recent researches demonstrated the successful fabrication of stimuli-responsive NMOF systems based on acidic pH conditions in tumor microenvironment [14] [15] [16] and the overexpressed biomarkers in cancer cells, such as vascular endothelial growth factor (VEGF) 17 and folate reporter (FR). 18, 19 As shown in Figure 1 , this review summarized the studies on the diagnostic and therapeutic applications of NMOFs in the last 5 years. The implication of NMOFs in combination cancer therapies was especially emphasized. The remaining challenges and future directions of NMOFs translational studies were highlighted.
Implication of NMOFs in Biomedical Imaging
The rapid development of biomedical imaging has greatly facilitated the early detection of cancers. The metal ions or clusters on NMOFs make them promising candidates as contrast agents for biomedical imaging, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and optical imaging (OI). Compared with traditional small-molecule contrast agents that are restricted by nonspecific distribution and rapid pharmacokinetics, NMOFs-based contrast agents are easily functionalized. In addition, NMOFs can co-deliver multiple biomolecules at the same time, so they can be used for Figure 1 The applications of NMOFs in diagnostic and therapeutic strategies for cancers. Abbreviations: MRI, magnetic resonance imaging; CT, computed tomography; PET, positron emission tomography; OI, optical imaging; NMOFs, nanoscale metal-organic frameworks; RT, radiotherapy; PDT, photodynamic therapy; PTT, photothermal therapy. 
CT
Due to high spatial resolution, deep tissue penetration, and 3-dimensional (3D) visibility, CT has been found increasing use in the diagnosis and treatment of cancers in recent years. 37 NMOFs served as contrast agents for CT imaging due to the incorporation of high Z element. 38 Owing to the large X-ray absorption coefficient, gold nanoparticles were widely used as contrast agents for CT imaging. 39 Zr-UiO-66/Py-PGA-PEG-F3. F3 peptide functioned as tumor-targeting ligand because it exhibited potent binding to tumor cells. In addition, the NMOFs showed a high loading capacity of DOX. This study suggested the potential of NMOFs for PET-guided tumor-targeted drugs delivery. In addition, in vivo safety evaluation confirmed that there was no observable acute, medium, or chronic toxicity. UiO-66@DOPA-LB exhibited improved biostability and prolonged circulation time, which endowed it great potential to serve as a nanocarrier for imaging agents. When labeling with NIR dye, IR-800, UiO-66@DOPA-LB-IR -800 exhibited superior capability for the detection of small tumor lesions at early stages.
Implication of NMOFs in Individual Cancer Therapy
A major reason for the failure of conventional cancer treatment is the inability of therapeutic drugs to be efficiently directed to tumor sites without damage to healthy tissues and organs. NOMFs not only improve the effects of traditional treatments such as RT and chemotherapy, but also benefit the newly development methods of phototherapy due to their excellent characteristics ( Table 2) .
Implication of NMOFs in RT
RT is a potent strategy to eliminate tumors. About half of cancer patients need at least one course of RT at different stages of treatment. 65 However, traditional radiotherapeutic approaches lacked specificities to cancer cells and may trigger severe side effects. Therefore, it is of significant importance to explore effective methods to enhance the efficacy of RT in tumor tissues and reduce its adverse effects on normal tissues. NMOFs containing high-Z elements showed promising potential to enhance RTinduced tumor fading due to their strong X-ray attenuation capabilities. 66 Ni et al 42 reported that Hf-DBB-Ru served as a mitochondria-targeted NMOF for radiotherapyradiodynamic therapy (RT-RDT 
Implication of NMOFs in Chemotherapy
Low bioavailability, poor tumor specificity and intolerable systemic toxicity are main obstacles for the clinical practice of chemotherapy. 67 To overcome these disadvantages, NMOFs were used as drug delivery platforms to specifically target tumor tissues and controllably release anti-cancer drugs. 17 In conclusion, smart theranostic platforms that combine tumor targeting, stimuli-responded release of anticancer drugs can be achieved by NMOFs, thus to realize imaging-guided precise chemotherapy.
Implication of NMOFs in Phototherapy
Phototherapy is an effective anticancer intervention that relies on light activation of photoactive materials localized 72 In both cases, delivery of PSs to the tumor tissues is of significant importance.
Implication of NMOFs in PDT
PDT combines 3 components, namely PS, light source and oxygen, and has emerged as an attractive new method of tumor treatment. Upon irradiation, the excited PS transfers energy to the surrounding oxygen to generate reactive oxygen species (ROS), particularly 1 O 2 , resulting in cell death and tumor-specific immunity. 71, 73 PDT provides an effective local cancer treatment by eradicating malignant tumors without damages to the surrounding normal tissues. However, owing to the poor water solubility and light penetration depth of traditional PSs, the clinical application of PDT is potentially limited. Recently, photosensitive agent-based NMOFs were designed to enhance PDT. 51, 52, 61, 74 Proper size and the micropore of NMOFs allowed high PS loadings without self-quenching, whereas the porous structures of NMOFs facilitated the diffusion of ROS, thus leading to improved efficacy in PDT. 74 Lin's group reported the first successful synthesis of a porphyrin-based NMOF, DBP-UiO, as an efficient PS in PDT for resistant head and neck cancer. 51 They further optimized the design of NMOF via reducing the porphyrin ligands to its chlorin counterpart and synthesized the first chlorin-based NMOF, DBC-UiO. The authors demonstrated the superior PDT efficacy of DBC-UiO over DBPUiO both in vitro and in vivo in 2 colon cancer models. 
Implication of NMOFs in Other Cancer Therapies Nucleic Acid-Based Cancer Detection and Therapeutics
NMOFs were used to deliver nucleic acids such as DNA, 76 small interfering RNA (siRNA) 68, 77 and microRNA. 78, 79 Morris et al 76 demonstrated that UiO-66-N 3 NMOFs had the ability to deliver DNA to HeLa cells to achieve 
Nitric Oxide (NO) Delivery
Recently, free-radical gas NO has drawn widespread attention in cancer treatment. 83, 84 NMOFs have been reported for use in NO delivery due to suitable characteristics. 85 Zhang et al 25 developed a Mn-porphyrin NMOF platform as a novel theranostic system for MRI-guided controllable NO release and PTT synergetic therapy under single NIR irradiation. This platform showed effective tumor accumulation in vivo.
Implication of NMOFs in Combination Cancer Therapy
Generally, individual cancer therapy approach cannot eliminate tumor effectively. The combination of two or more therapeutic treatments has been considered as a promising cancer treatment strategy due to fewer side effects and synergistic anti-cancer efficacy. 86 The NMOFs have been examined for tumor therapies both in vitro and in vivo (Table 3) .
Dual Chemotherapy Drugs
Single chemotherapy drug always needs a high dose, which brings severe side effects. Zhang et al 69 firstly
established a co-delivery platform of 2 different chemical drugs based on nanoscale ZIF-90, which not only reduced the drug toxicity, but also achieved effective therapeutic synergy. Owing to high surface area and excellent biocompatibility, ZIF-90 was chosen as the framework of the Abbreviations: RT-RDT, radiotherapy-radiodynamic therapy; PDT, photodynamic therapy; PTT, photothermal therapy; IDOi, Indoleamine 2.3-dioxygenase inhibitor; αPD-1, anti-programmed death-1; α-PD-L1, anti-programmed death-ligand 1; 5-FU, 5-fluorouracil; DOX, doxorubicin; NP,nanoparticles; PEG, polyethylene glycol; TPZ, tirapazamine; TCPP, tetra(4-carboxyphenyl)porphine; BTC, 1,3,5-benzenetricarboxylate; CPT, camptothecin; SNO, S-Nitrosothiol; TCPP, tetra(4-carboxyphenyl)porphine; TBC, tetra(p-benzoato)chlorin; TBP, 5,10,15,20-tetra(p-benzoato)porphyrin; DBA, 2.5-di(p-benzoato)aniline.
NMOFs. This co-delivery system was generated by attaching DOX on the surface of nanoscale ZIF-90, while encapsulating 5-FU into the pores of the framework at the same time. Moreover, ZIF-90 exhibited more stability at high pH, while at lower pH, the framework of ZIF-90 was instable. Due to the acidic environment at tumor sites, 5-FU@ZIF-90-DOX could achieve cancer-targeted codelivery and controlled release of DOX and 5-Fu.
Chemotherapy/siRNAs
RNA interference (RNAi) is a sequence-specific and posttranscriptional gene silencing technique, which can be used to regulate protein expression and is currently used as a tool to modulate disease-related genes, such as MDR genes. With the unique features of good biocompatibility and high sensitivity, Au nanoparticles were recognized as ideal materials of this NMOF. Due to good stability, low toxicity and strong NIR absorbance, Cu 3 (BTC) 2 was selected to enhance the photothermal effect. In vitro cytotoxicity studies revealed that even at a high concentration, Au@Cu 3 (BTC) 2 nanoparticles exhibited very low cytotoxicity on A549, beas-2b, MCF-7 and HeLa cells. In vivo study indicated that there were no obvious body weight losses of A549 xenograft model, suggesting its safety. This work inspired further researches on the invention of more multifunctional theranostic platforms based on NMOFs.
PDT/RT
Severe toxicity greatly limits the potential of RT. Combining RT with other therapeutic approaches has drawn great attention in the past few years, which significantly enhanced anticancer efficacy and decreased systemic toxicity. 104, 105 In 2016, Liu et al 66 reported the successful synthesis of novel NMOFs that were used for the combination of PDT and RT in a murine breast cancer model. In this NMOFs platform, TCPP served as a PS of PDT, and Hf 4+ with strong X-ray attenuation ability functioned as a radiosensitizer to enhance RT-induced tumor killing. In addition, these NMOFs showed tumor targeting due to the EPR effect. In vivo study indicated that the mice bearing 4T1 tumors showed greatly tumor shrinking in the combined therapy group (i.v. injection with NMOF-PEG + X-ray + Laser) compared with respective mono-therapies.
PDT/Immunotherapy
PDT can efficiently eliminate local tumors but is unable to control distant metastases. Immunotherapy, especially the application of immune checkpoint inhibitors, has achieved combined NMOF-enabled RD-RDT therapy with IDOi both local and systemic tumors in mouse models of breast and colorectal cancer.
Challenges of the Clinical Translation of NMOFs
By combining both biomedicine imaging agents and anticancer drugs in a single NMOF platform, we can achieve both diagnosis and therapy of cancers at the same time. Due to passive targeting and active targeting of NMOFs, imaging agents and therapeutic drugs can accumulate at the tumor sites. Controlled and sustained drug delivery can be realized due to the existence of stimuli-responsive NMOFs. In addition, many surface modification approaches, such as PEG modification, have been employed, which improved the stability and long-circulating property of NMOFs efficiently. Moreover, combined therapeutic strategies based on NMOFs substantially enhanced the anti-tumor effect (Table 3) , and researchers highly valued the importance of in vivo study. Figure 2 presents the schematic of the synthesis and the implication of NMOFs in cancer theranostics briefly. Although significant progress has been made in the development of NMOFs for biomedical imaging and anti-cancer drug delivery, there were still some challenges which limit their translation to clinical settings. Firstly, the long-term toxicity and biosafety of NMOFs still need to be further evaluated. Although most NMOFs systems have no significant acute or subacute cytotoxicity in mice, but the long-term safety is to be examined. Secondly, there are significant differences between animal models and humans. Although many NMOFs platforms displayed efficient anti-cancer effects in animal models, its functions in the human body are still to be investigated. In addition, although targeted ligands can be incorporated into the NMOFs to realize tumor-targeted delivery of imaging agents and anticancer drugs, it is still quite difficult to distinguish cancerous and normal cells. Moreover, the construction of NMOFs systems often involves complex chemical synthesis and post-modifications Further studies are required to fully validate the implication of NMOFs at the clinical translation stage.
Given recent technical advancements over the last decades, smart and targeted NMOFs as cancer theranostic platforms will be further improved to enhance anticancer effects and better life quality for cancer patients.
